Dataset from A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Subjects With Hypertension

This study is a randomized, placebo-controlled, double-blind, multi-center study to evaluate efficacy and safety of different doses of CS-3150 compared to placebo in Japanese hypertensive subjects. Primary endpoint is change from baseline in sitting systolic and diastolic blood pressure.

本研究为一项随机、安慰剂对照、双盲多中心临床试验，旨在评估不同剂量CS-3150对比安慰剂在日本高血压受试者中的疗效与安全性。主要终点为坐位收缩压及舒张压较基线的变化幅度。